Cancer Screening Services For Medical Specialties
-
Manufactured by Elpisciencebased in CHINA
Elpiscience’s proprietary discovery technologies enable efficient generation of innovative cancer ...
-
based in USA
Indication: Breast Cancer. Improved detection and differentiation on routine breast ultrasound, enabling faster, more accurate, and cheaper detection and treatment of breast cancer. ISSUED ...
-
based in USA
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
-
based in USA
Mammograms are x-ray exams of the breast. They are most often used to screen for breast cancer in women who have no symptoms. Mammograms and other breast imaging tests can also be used in women who have breast symptoms, such as a lump or pain, or who have a suspicious change seen on a screening mammogram. Mammography is the only screening tool that has been demonstrated through large randomized ...
-
Manufactured by Grail, Inc.based in USA
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
-
Manufactured by Grail, Inc.based in USA
Development of a Blood Test with Prospective Study Cohort of 100,000 Participants. The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants ...
-
Manufactured by Immatics N.V.based in GERMANY
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
-
Manufactured by Greenwich LifeSciences, Inc.based in USA
Cancer Immunotherapies are a New Method of Cancer Treatment. Among the more established treatment options, such as surgery, chemotherapy, targeted therapy, and radiation therapy, cancer immunotherapy is a rapidly emerging and important field. It has led to new clinical research studies and has garnered the attention of biotechnology and pharmaceutical companies, regulatory agencies, payors and ...
-
Manufactured by Fluxion Biosciences Incbased in USA
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the data…it’s that ...
-
Manufactured by MiraDxbased in USA
Independent of their BRCA1/BRCA2 mutational status, ...
-
Manufactured by Self-screen B.V.based in NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as self sampling (validations for ...
-
based in FRANCE
Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the genetic characteristics of its tumor. Apollon Bioteck manufactures and promotes ready to use IVD assays for companion Diagnostics. These assays are based on innovative ...
-
Manufactured by BioCheck, Inc.based in USA
BioCheck provides a variety of services including: Custom Immunoassay Development, ELISA, Ultrasensitive Immunoassays using Simoa (single molecule array) Technology, Antibody Purification and Conjugation, Contract Manufacturing and ...
-
by Oncodesignbased in FRANCE
EXPLORE, a new service to identify and validate therapeutic targets, primarily cancer treatments – an area of expertise and excellence at Oncodesign to discover and investigate preclinical proofs of concept involving a wide variety of different approaches and anti-cancer mechanisms of action. EXPLORE, is the combination of our OncoSNIPER platform and a tailored and well established ...
-
based in USA
Optimise your Anatomic Pathology processes. Our comprehensive Anatomic Pathology solution is relied upon by healthcare professionals to test, diagnose and treat millions of patients every day. Our fully scalable and interoperable solution increases the efficiency of both routine tasks and the most complex ...
-
based in USA
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about their tumor to determine the most suitable treatment plan. The test ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
-
Manufactured by UroTechbased in USA
UroTech is devoted to keeping pace with the growing need for better and more widespread brachytherapy services. Like UroTech's thermotherapy and lithotripsy services, UroTech delivers top of the line equipment and expertise to facilities seeking to improve their services for prostate cancer. We work hand in hand with radiation oncologists, physicists, and urologists to develop Centers of ...
-
based in USA
Histology, tissue staining using the latest in automated staining platforms, and digital pathology services form the foundation of a strong anatomic pathology program. Anatomic Pathology at NeoGenomics offers in-house comprehensive diagnostic services, backed by highly trained professionals, to provide oncologists and pathologists the information they need to determine the best treatment strategy ...
-
Manufactured by Aindra Systemsbased in INDIA
One woman dies every 2 minutes globally due to Cervical Cancer. Currently, there exists no reliable, smart and fast solution for the screening of Cervical Cancer in all developing nations. Although cervical cancer has a higher gestation period, due to lack of affordable and accessible screening tests, the count of women detected with Cervical Cancer is rising and so is the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you